The Psychedelic Education Market is Expanding Rapidly This rapid expansion is occurring in response to growth— both real and perceived- in the greater...
The psychedelics industry has huge potential shackled by uncertainty. The post What’s in store for psychedelics in 2024 appeared first on Green Market...
The founder of TOMS has taken interest, too. The post Tara Mind attracts $8M to bring ketamine therapy to workplace benefits appeared first on Green Market...
Awakn Life Sciences Corp. (CBOE: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn”), a clinical-stage biotechnology company developing medication-assisted treatments...
Awakn Life Sciences Corp. (CBOE: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn”), a clinical-stage biotechnology company developing medication-assisted treatments...
The study will focus on treatment for four medical conditions. The post EU awards €6.5 million for psychedelic drug trial appeared first on Green Market...
2023— the year that everyone in the psychedelic industry prepared for takeoff. Well, theoretical (but probable) take off. And, just a few weeks before...
Explore how psychedelic-assisted therapy, particularly with psilocybin, offers new, promising avenues for treating nicotine and other addictions.
Highlights: Incannex Healthcare Inc. (Nasdaq: IXHL), (‘Incannex’ or the ‘Company’), a pharmaceutical company developing unique medicinal cannabinoid...
Q1 Fiscal 2024 Highlights All financial results are reported in Canadian dollars unless otherwise stated. VANCOUVER, BC, Jan. 15, 2024 /CNW/ – Numinus...